SCLXW vs. GRFS, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, and AONC
Should you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Grifols (GRFS), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), and American Oncology Network (AONC). These companies are all part of the "medical" sector.
Scilex (NASDAQ:SCLXW) and Grifols (NASDAQ:GRFS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.
Grifols has higher revenue and earnings than Scilex.
Grifols received 348 more outperform votes than Scilex when rated by MarketBeat users.
Grifols has a consensus target price of $10.50, indicating a potential upside of 53.51%. Given Grifols' higher possible upside, analysts plainly believe Grifols is more favorable than Scilex.
In the previous week, Grifols had 1 more articles in the media than Scilex. MarketBeat recorded 1 mentions for Grifols and 0 mentions for Scilex. Grifols' average media sentiment score of 0.32 beat Scilex's score of 0.00 indicating that Grifols is being referred to more favorably in the news media.
Grifols has a net margin of 0.90% compared to Scilex's net margin of 0.00%. Grifols' return on equity of 1.73% beat Scilex's return on equity.
Summary
Grifols beats Scilex on 8 of the 8 factors compared between the two stocks.
Get Scilex News Delivered to You Automatically
Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SCLXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SCLXW vs. The Competition
Related Companies and Tools
